ArticleThe Canadian journal of urology2026
Penile shaft reconstruction after cream self-injection: a case report.
Article in The Canadian journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPenile augmentation through injectable substances is becoming increasingly common. A growing number of aesthetic clinics are developing penile enlargement procedures using various injectable materials. Although these procedures are now performed in more controlled and medically supervised environments, their long-term outcomes remain poorly understood. The promotion of such medical treatments contributes to an increasing interest among adult males in self-injection as a method to alleviate psychological distress associated with penile size concerns. At the same time, access to injectable substances through unofficial or unregulated sources has become increasingly easy. Tor our knowledge, we report the first documented case of self-injection with Garamycin® (gentamicin) cream, contributing to the literature on the often multidisciplinary management of penile enlargement injections, a field still lacking well-established guidelines. CASE DESCRIPTION: This case report describes a young patient who self-injected Garamycin® into the penis for the purpose of enlargement. He presented to our urology department with worsening symptoms, including severe and poorly tolerated pain. His primary request was prompt relief of pain while preserving, as much as possible, the aesthetic appearance and functional integrity of his penis. This case required a multi-stage surgical approach to salvage the penis and preserve both its structural integrity and functional outcome.
conclusionsTo our knowledge, this case report documents the first reported instance of Garamycin® injection performed for the purpose of penile enlargement. It provides insight into the clinical course of such penile cream injections, demonstrates that a two-stage scrotal flap can achieve both functional and aesthetic outcomes, and highlights the importance of comprehensive management particularly addressing the traumatic impact of penile deformity secondary to inflammation and/or infection, as well as the body dysmorphic concerns often associated with these cases.
Indexed as
Identifiers
41800518What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.